Kodiak Sciences Inc (KOD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $27.98
• Market Cap: $1.69B
• EPS: $-4.12
• 52-Week High: $31.18
• 52-Week Low: $1.92

Market Sentiment

Kodiak Sciences Inc currently has a Bullish sentiment score of 0.28.

About Kodiak Sciences Inc

Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, specializing in the development of innovative therapies for retinal diseases. Utilizing its proprietary technologies, Kodiak addresses critical unmet medical needs in ophthalmology, underpinned by a robust and diverse pipeline aimed at enhancing patient outcomes. With a strategic focus on pioneering revolutionary treatments, Kodiak is poised to significantly influence the global healthcare lands...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Kodiak Sciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does KOD pay dividends?

Kodiak Sciences Inc (KOD) does not currently pay a regular dividend.

What is KOD's market cap?

Kodiak Sciences Inc (KOD) has a market capitalization of $1.69B with a current stock price of $27.98.